Molecular magnetic resonance imaging approaches used to aid in the understanding of the tissue regeneration marker met in vivo: Implications for tissue engineering

Tissue Engineering - Part A

Volumn 16, Issue 2, 2010, Pages 365-371

  Towner, Rheal A ^a   Smith, Nataliya ^a   Asano, Yasuko ^a   Doblas, Sabrina ^a   Saunders, Debra ^a   Silasi Mansat, Robert ^a   Lupu, Florea ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; DEXTRAN; GLUCOSE; IRON ORES; MAGNETIC RESONANCE; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; OXIDE MINERALS; PHOSPHATASES; PROBES; RAT CONTROL; TUMORS;

COATED NANOPARTICLES; COVALENTLY BOUND; ENGINEERED TISSUES; HEPATOCYTE GROWTH FACTOR; IN-VIVO; MOLECULAR MARKER; MOLECULAR PROBES; MOLECULAR TARGETING; MR SIGNALS; NORMAL TISSUE; SCATTER FACTOR; TISSUE ENGINEERING APPLICATIONS; TISSUE REGENERATION; TUMOR TISSUES; TYROSINE KINASE; WESTERN BLOTS;

TISSUE ENGINEERING;

RATTUS; RODENTIA;

BIOLOGICAL MARKER; FERRIC ION; FERRIC OXIDE; NANOPARTICLE; SCATTER FACTOR RECEPTOR;

ANIMAL; ARTICLE; CHEMISTRY; FISCHER 344 RAT; GLIOMA; MALE; METABOLISM; METHODOLOGY; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RAT; STAINING; TISSUE ENGINEERING; TISSUE REGENERATION;

ANIMALS; BIOLOGICAL MARKERS; FERRIC COMPOUNDS; GLIOMA; GUIDED TISSUE REGENERATION; MAGNETIC RESONANCE IMAGING; MALE; MOLECULAR IMAGING; NANOPARTICLES; PROTO-ONCOGENE PROTEINS C-MET; RATS; RATS, INBRED F344; STAINING AND LABELING; TISSUE ENGINEERING;

EID: 77049083474     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0234     Document Type: Conference Paper

References (48)

1. Holmes, O., Pillozzi, S., Deakin, J.A., Carafoli, F., Kemp, L., Butler, P.J., Lyon, M., and Gherardi, E. Insights into the structure=function of hepatocyte growth factor=scatter factor fromstudieswithindividualdomains. JMolBiol367,395,2007.
2. Bladt, F., Riethmacher, D., Isenmann, S., Aguzzi, A., and Birchmeier, C. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 376, 768, 1995.
3. Caton, A., Hacker, A., Naeem, A., Livet, J., Maina, F., Bladt, F., Klein, R., Birchmeier, C., and Guthrie, S. The branchial arches and HGF are growth-promoting and chemoattractant for cranial motor axons. Development 127, 1751, 2000.
4. Schmidt, C., Bladt, F., Goedecke, S., Brinkmann, V., Zschiesche, W., Sharpe, M., Gherardi, E., and Birchmeier, C. Scatter factor=hepatocyte growth factor is essential for liver development. Nature 373, 699, 1995.
5. Borowiak, M., Garratt, A.N., Wüstefeld, T., Strehle, M., Traut-wein, C., and Birchmeier, C. Met provides essential signals for liver regeneration. Proc Natl Acad Sci USA 101, 10608, 2004.
6. Huh, C.G., Factor, V.M., Sánchez, A., Uchida, K., Conner, E.A., and Thorgeirsson, S.S. Hepatocyte growth factor=c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci USA 101, 4477, 2004.
7. Dai, C., Huh, C.G., Thorgeirsson, S.S., and Liu, Y. Beta-cell-specific ablation of the hepatocyte growth factor receptor results in reduced islet size, impaired insulin secretion, and glucose intolerance. Am J Pathol 167, 429, 2005.
8. Neuss, S., Becher, E., Wöltje, M., Tietze, L., and Jahnen-Dechent, W. Functional expression of HGF and HGF receptor=c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing. Stem Cells 22, 405, 2004.
9. Schmidt, K.F., Ziu, M., Schmidt, N.O., Vaghasia, P., Car-gioloi, T.G., Doshi, S., Albert, M.S., Black, P.M., Carroll, R.S., and Sun, Y. Volume reconstruction techniques improve the correlation between histological and in vivo tumor volume measurements in mouse models of human gliomas. J Neu-rooncol 68, 207, 2004.
10. Badruddoja, M.A., Krouwer, H.G., Rand, S.D., Rebro, K.J., Pathak, A.P., and Schmainda, K.M. Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps. Neurooncology 5, 235, 2003.
11. Zhang, X., Wu, J., Gao, D., Fei, Z., Qu, Y., and Jing, J. Development of a rat C6 brain tumor model. Chin Med J 115, 455, 2002.
12. Zhou, R., Mazurchuk, R., and Straubinger, R.M. Antivascular effects of doxorubicin-containing liposomes in an intracranial rat brain tumor model. Cancer Res 62, 2561, 2002.
13. Shen, T., Weissleder, R., Papisov, M., Bogdanov, A., Jr., and Brady, T.J. Monocrystalline iron oxide nanocompounds (MION): physiochemical properties. Magn Reson Med 29, 599, 1993.
14. McCarthy, J.R., Kelly, K.A., Sun, E.Y., and Weissleder, R. Targeted delivery of multifunctional magnetic nanoparticles. Nanomedicine 2, 153, 2007.
15. Bulte, J.W., Douglas, T., Witwer, B., Zhang, S.C., Strable, E., Lewis, B.K., Zywicke, H., Miller, B., van Gelderen, P., Moskowitz, B.M., Duncan, I.D., and Frank, J.A. Magneto-dendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 19, 1141, 2001.
16. Trusolino, L., and Comoglio, P.M. Scatter-factor and sema-phorin receptors: cell signalling for invasive growth. Nat Rev 2, 289, 2002.
17. Josephson, L., Tung, C.-H., Moore, A., and Weissleder, R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem 10, 186, 1999.
18. Palmacc, S., and Josephson, L. Synthesis of polysaccharide covered superparamagnetic oxide colloids. U.S. Patent 5,262,176, 1993
19. Hermanson, G. Bioconjugate Techniques. New York: Academic Press, 1996, pp. 456-493, 494-527.
20. Doblas, S., Saunders, D., Tesiram, Y.A., Kshirsagar, P., Pye, Q., Oblander, J., Gordon, B., Kosanke, S., Floyd, R.A., and Towner, R.A. Phenyl-tert-butyl nitrone induces tumor regression and decreases angiogenesis in a C6 rat glioma model. Free Radic Biol Med 44, 63, 2008.
21. Towner, R.A., Smith, N., Doblas, S., Tesiram, Y., Saunders, D., Cranford, R., Silasi-Mansat, R., Herlea, O., and Lupu, F. In vivo detection of c-Met expression in a rat C6 glioma model. J Cell Mol Med 12, 174, 2008.
22. Barth, R.F. Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neurooncol 36, 91, 1998.
23. Grobben, B., De Deyn, P.P., and Slegers, H. Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell Tissue Res 310, 257, 2002.
24. Towner, R.A., Smith, N., Tesiram, Y.A., Abbott, A., Saun-ders, D., Blindauer, R., Herlea, O., Silasi-Mansat, R., and Lupu, F. In vivo detection of c-Met expression in a rat he-patocarcinogenesis model using molecularly targeted magnetic resonance imaging. Mol Imaging 6, 18, 2007.
25. Huh, Y.-M., Jun, Y.-W., Song, H.-T., Kim, S., Choi, J.-S., Lee, J.-H., Yoon, S., Kim, K.-S., Shin, J.-S., Suh, J.-S., and Cheon, J. In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. J Am Chem Soc 127, 12387, 2005.
26. Thorek, D.L.J., Chen, A.K., Czupryna, J., and Tsourkas, A. Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng 34, 23, 2006.
27. Kresse, M., Wagner, S., Pfefferer, D., Lawaczeck, R., Elste, V., and Semmler, W. Targeting of ultrasmall super-paramagnetic iron oxide (USPIO) particles to tumor cells in vivo by using transferring receptor pathways. Magn Reson Med 40, 236, 1998.
28. Ichikawa, T., Hogemann, D., Saeki, Y., Tyminski, E., Terada, K., Weissleder, R., Chiocca, E.A., and Basilion, J.P. MRI of transgene expression: correlation to therapeutic gene expression. Neoplasia 4, 523, 2002.
29. Choi, H., Choi, S.R., Zhou, R., Kung, H.F., and Chen, I.W. Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery. Acad Radiol 11, 996, 2004.
30. Moore, A., Medarova, Z., Potthast, A., and Dai, G. In vivo targeting of underglycosylated MUC-1 tumor antigen using a multimodal imaging probe. Cancer Res 64, 1821, 2004.
31. Kachra, Z., Beaulieu, E., Delbecchi, L., Mousseau, N., Ber-thelet, F., Moumdjian, R., Del Maestr, R., and Beliveau, R. Expression of matrix metalloproteinases and their inhibitors in human brain tumors. Clin Exp Metastasis 17, 555, 1999.
32. Kelly, K.A., Setlur, S.R., Ross, R., Anbazhagan, R., Waterman, P., Rubin, M.A., and Weissleder, R. Detection of early prostate cancer using a hepsin targeted imaging agent. Cancer Res 68, 2286, 2008.
33. Artemov, D., Mori, N., Okollie, B., and Bhujwalla, Z.M. MR molecular imaging of the Her-2=neu receptor in breast cancer cells using targeted iron oxide nanoparticles. Magn Re-son Med 49, 403, 2003.
34. Funovics, M.A., Kapeller, B., Hoeller, C., Su, H.S., Kunstfeld, R., Puig, S., and Macfelda, K. MR imaging of the her2=neu and 9.2.27 tumor antigens using immunospecific contrast agents. Magn Reson Imaging 22, 843, 2004.
35. McCarthty, J.R., and Weissleder, R. Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev 60, 1241, 2009.
36. Tsourkas, A., Shinde-Patil, V.R., Kelly, K.A., Patel, P., Wol-ley, A., Allport, J.R., and Weissleder, R. In vivo imaging of activated endothelium using an anti-VCAM-1 magnetoop-tical probe. Bioconjug Chem 16, 576, 2005.
37. Kang, H.W., Josephson, L., Petrovsky, A., Weissleder, R., and Bogdanov, A., Jr. Magnetic resonance imaging of in-ducible E-selectin expression in human endothelial cell culture. Bioconjug Chem 13, 122, 2002.
38. Sosnovik, D.E., Nahrendorf, M., and Weissleder, R. Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications. Basic Res Cardiol 103, 122, 2008.
39. Arrieta, O., Garcia, E., Guevara, P., Garcia-Navarrete, R., Ondarza, R., Rembao, D., and Sotelo, J. Hepatocyte growth factor is associated with poor prognosis of malignant glio-mas and is a predictor for recurrence of meningiomas. Cancer 94, 3210, 2002.
40. Koochekpour, S., Jeffers, M., Rulong, S., Taylor, G., Kline-berg, E., Hudson, E.A., Resau, J.H., and Vande Woude, G.F. Met and hepatocyte growth factor=scatter factor expression in human gliomas. Cancer Res 57, 5391, 1997.
41. Lamszus, K., Liang, J., Laterra, J., Zagzag, D., Way, D., Witte, M., Goldberg, I.D., and Rosen, E.M. Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells. Int J Cancer 75, 19, 1998.
42. Moriyama, T., Kataoka, H., Kawano, Y., Yokogami, K., Nakano, S., Goya, T., Uchino, H., Koono, M., and Wakasaka, S. Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas. Cancer Lett 124, 149, 1998.
43. Amicone, L., Terradillos, O., Calvo, L., Costabile, B., Cic-chini, C., Della Rocca, C., Lozupone, F., Piacentini, M., Buendia, M.A., and Tripodi, M. Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signaling in the control of liver homeostasis and transformation. Oncogene 21, 1335, 2002.
44. DiRenzo, M.F., Narshimhan, R.P., Olivero, M., Bretti, S., Giordano, S., Medico, E., Gaglia, P., Zara, P., and Comoglio, P.M. Expression of the Met=HGF receptor in normal and neoplastic tissues. Oncogene 6, 1997, 1991.
45. Jiang, Y., Xu, W., Lu, J., He, F., and Yang, X. Invasiveness of hepatocellular carcinoma cell lines: contribution of hepato-cyte growth factor, c-met, and transcription factor Ets-1. Biochem Biophys Res Commun 286, 1123, 2001.
46. Yamashita, J., Ogawa, M., Yamashita, S., Nomura, K., Kur-amoto, M., Saishoji, T., and Shin, S. Immunoreactive hepa-tocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res 54, 1630, 1994.
47. Yu, Y., and Merlino, G. Constitutive c-MET signaling through a nonautocrine mechanism promotes metastasis in a trans-genic transplantation model. Cancer Res 62, 2951, 2002.
48. Zeng, Z., Weiser, M.R., D'Alessio, M., Grace, A., Shia, J., and Paty, P.B. Immunoblot analysis of c-Met expression in human colorectal cancer: overexpression is associated with advanced stage cancer. Clin Exp Metastasis 21, 409, 2004.